+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Glucose Monitoring Devices Market Research Report by Type (Diabetes Monitoring Devices and Insulin Delivery Devices), Application, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 133 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5532690
UP TO OFF until Dec 31st 2022
The United States Glucose Monitoring Devices Market size was estimated at USD 1,261.51 million in 2021, USD 1,376.26 million in 2022, and is projected to grow at a CAGR 11.11% to reach USD 2,373.80 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Glucose Monitoring Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Diabetes Monitoring Devices and Insulin Delivery Devices. The Diabetes Monitoring Devices is further studied across Continuous Glucose Monitoring Devices, Glucose Meter, Glucose Test Strips, and Lancets and Lancing Devices. The Insulin Delivery Devices is further studied across Insulin Pens, Insulin Pumps, and Insulin Syringes.
  • Based on Application, the market was studied across Gestational Diabetes, Type 1 Diabetes, and Type 2 Diabetes.
  • Based on End User, the market was studied across Diagnostics, Home Settings, and Hospitals.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Glucose Monitoring Devices market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Glucose Monitoring Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Glucose Monitoring Devices Market, including AstraZeneca plc, B. Braun Melsungen AG, Bayer HealthCare AG, Becton, DexCom, Inc., Dickinson & Company, GE Healthcare, GlaxoSmithKline plc, Insulet Corporation, Johnson & Johnson, Lupin Limited, Medtronic, Inc., Merck & Co., Inc., Nova Biomedical Corporation, Novartis International AG, Omron Healthcare, Philips Healthcare, ResMed Inc., Roche, Senseonics, and Takeda Pharmaceutical Company Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Glucose Monitoring Devices Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Glucose Monitoring Devices Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Glucose Monitoring Devices Market?
4. What is the competitive strategic window for opportunities in the United States Glucose Monitoring Devices Market?
5. What are the technology trends and regulatory frameworks in the United States Glucose Monitoring Devices Market?
6. What is the market share of the leading vendors in the United States Glucose Monitoring Devices Market?
7. What modes and strategic moves are considered suitable for entering the United States Glucose Monitoring Devices Market?
Frequently Asked Questions about the U.S. Glucose Monitoring Devices Market

What is the estimated value of the U.S. Glucose Monitoring Devices Market?

The U.S. Glucose Monitoring Devices Market was estimated to be valued at $1261.51 Million in 2021.

What is the growth rate of the U.S. Glucose Monitoring Devices Market?

The growth rate of the U.S. Glucose Monitoring Devices Market is 11.1%, with an estimated value of $2373.8 Million by 2027.

What is the forecasted size of the U.S. Glucose Monitoring Devices Market?

The U.S. Glucose Monitoring Devices Market is estimated to be worth $2373.8 Million by 2027.

Who are the key companies in the U.S. Glucose Monitoring Devices Market?

Key companies in the U.S. Glucose Monitoring Devices Market include AstraZeneca plc, B. Braun Melsungen AG, Bayer HealthCare AG, Becton, DexCom, Inc., Dickinson & Company, GE Healthcare, GlaxoSmithKline plc and Johnson & Johnson.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Glucose Monitoring Devices Market, by Type
6.1. Introduction
6.2. Diabetes Monitoring Devices
6.2.1. Continuous Glucose Monitoring Devices
6.2.2. Glucose Meter
6.2.3. Glucose Test Strips
6.2.4. Lancets and Lancing Devices
6.3. Insulin Delivery Devices
6.3.1. Insulin Pens
6.3.2. Insulin Pumps
6.3.3. Insulin Syringes
7. Glucose Monitoring Devices Market, by Application
7.1. Introduction
7.2. Gestational Diabetes
7.3. Type 1 Diabetes
7.4. Type 2 Diabetes
8. Glucose Monitoring Devices Market, by End User
8.1. Introduction
8.2. Diagnostics
8.3. Home Settings
8.4. Hospitals
9. California Glucose Monitoring Devices Market10. Florida Glucose Monitoring Devices Market11. Illinois Glucose Monitoring Devices Market12. New York Glucose Monitoring Devices Market13. Ohio Glucose Monitoring Devices Market14. Pennsylvania Glucose Monitoring Devices Market15. Texas Glucose Monitoring Devices Market
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. AstraZeneca plc
17.2. B. Braun Melsungen AG
17.3. Bayer HealthCare AG
17.4. Becton
17.5. DexCom, Inc.
17.6. Dickinson & Company
17.7. GE Healthcare
17.8. GlaxoSmithKline plc
17.9. Insulet Corporation
17.10. Johnson & Johnson
17.11. Lupin Limited
17.12. Medtronic, Inc.
17.13. Merck & Co., Inc.
17.14. Nova Biomedical Corporation
17.15. Novartis International AG
17.16. Omron Healthcare
17.17. Philips Healthcare
17.18. ResMed Inc.
17.19. Roche
17.20. Senseonics
17.21. Takeda Pharmaceutical Company Limited
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES GLUCOSE MONITORING DEVICES MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES GLUCOSE MONITORING DEVICES MARKET DYNAMICS
FIGURE 8. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2027
FIGURE 11. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, 2019-2027 (USD MILLION)
FIGURE 28. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 30. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2027
FIGURE 32. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, 2019-2027 (USD MILLION)
FIGURE 33. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, 2019-2027 (USD MILLION)
FIGURE 35. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, 2019-2027 (USD MILLION)
FIGURE 37. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 39. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2027
FIGURE 41. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, 2019-2027 (USD MILLION)
FIGURE 42. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 43. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 45. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 46. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 47. CALIFORNIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. FLORIDA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. ILLINOIS GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. NEW YORK GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. OHIO GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. PENNSYLVANIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. TEXAS GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. UNITED STATES GLUCOSE MONITORING DEVICES MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 55. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES GLUCOSE MONITORING DEVICES MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE METER, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GLUCOSE TEST STRIPS, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY LANCETS AND LANCING DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN DELIVERY DEVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PENS, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN PUMPS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOME SETTINGS, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. CALIFORNIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 24. CALIFORNIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 25. CALIFORNIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 26. CALIFORNIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 27. FLORIDA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 28. FLORIDA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 29. FLORIDA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 30. FLORIDA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 31. ILLINOIS GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. ILLINOIS GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 33. ILLINOIS GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 34. ILLINOIS GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 35. NEW YORK GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 36. NEW YORK GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 37. NEW YORK GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 38. NEW YORK GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 39. OHIO GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 40. OHIO GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 41. OHIO GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 42. OHIO GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 43. PENNSYLVANIA GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. PENNSYLVANIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 45. PENNSYLVANIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 46. PENNSYLVANIA GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 47. TEXAS GLUCOSE MONITORING DEVICES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. TEXAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 49. TEXAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 50. TEXAS GLUCOSE MONITORING DEVICES MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 51. UNITED STATES GLUCOSE MONITORING DEVICES MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 52. UNITED STATES GLUCOSE MONITORING DEVICES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 53. UNITED STATES GLUCOSE MONITORING DEVICES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 54. UNITED STATES GLUCOSE MONITORING DEVICES MARKET RANKING
TABLE 55. UNITED STATES GLUCOSE MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2021
TABLE 56. UNITED STATES GLUCOSE MONITORING DEVICES MARKET MERGER & ACQUISITION
TABLE 57. UNITED STATES GLUCOSE MONITORING DEVICES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 58. UNITED STATES GLUCOSE MONITORING DEVICES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 59. UNITED STATES GLUCOSE MONITORING DEVICES MARKET INVESTMENT & FUNDING
TABLE 60. UNITED STATES GLUCOSE MONITORING DEVICES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 61. UNITED STATES GLUCOSE MONITORING DEVICES MARKET: LICENSE & PRICING

Companies Mentioned

  • AstraZeneca plc
  • B. Braun Melsungen AG
  • Bayer HealthCare AG
  • Becton
  • DexCom, Inc.
  • Dickinson & Company
  • GE Healthcare
  • GlaxoSmithKline plc
  • Insulet Corporation
  • Johnson & Johnson
  • Lupin Limited
  • Medtronic, Inc.
  • Merck & Co., Inc.
  • Nova Biomedical Corporation
  • Novartis International AG
  • Omron Healthcare
  • Philips Healthcare
  • ResMed Inc.
  • Roche
  • Senseonics
  • Takeda Pharmaceutical Company Limited

Methodology

Loading
LOADING...